查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1225347

戈謝病市場：按類型（戈謝病1,2,3型、其他）、診斷/治療（診斷、治療）、最終用戶（醫院、專科診所、家庭保健、其他）、按地區2023-2028

Gaucher Disease Market by Type (Gaucher Disease Type 1, Gaucher Disease Type 2, Gaucher Disease Type 3, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Specialty Clinics, Homecare, and Others), and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

市場概覽

  • 到 2022 年，全球戈謝病市場規模將達到 15.5 億美元。 展望未來，IMARC Group 預測到 2028 年將達到 23.5 億美元，2023 年至 2028 年的增長率 (CAGR) 為 7.07%。 越來越多的戈謝病患者、主要的研發活動以及藥物的可用性是推動市場的主要因素。
  • 戈謝病，也稱為溶□體貯積症，是一種罕見的遺傳代謝病，會影響人體分解和儲存脂肪的能力。 另一種是由葡萄糖腦甘脂□缺乏引起的，葡萄糖腦甘脂□會分解體內的葡萄糖腦甘脂□脂肪化學物質。 它伴隨著脾臟和肝臟腫大、貧血、容易瘀傷和出血、肺部問題、疲勞、癲癇發作和骨骼異常。 它是通過各種身體檢查、病史、實驗室檢查（例如血液檢查和影像學檢查）以及檢查基因突變的基因檢查來診斷的。 戈謝病的治療包括藥物、注射、□替代療法 (ERT)、骨髓移植和底物減少療法 (SRT)，以最大限度地減少症狀性疼痛並提高生活質量。它對

戈謝病市場趨勢

  • 目前，個人遺傳異常的流行率越來越高，戈謝病的流行率越來越高，是推動全球市場增長的主要因素。 此外，隨著老齡化社會的推進，治療戈謝病的需求越來越大。 此外，對戈謝病治療的財政支持和旨在減少醫療費用的健康保險制度的引入也在增加。 除此之外，人們對戈謝病症狀、診斷、治療可用性等的認識不斷提高，對市場產生了積極影響。 此外，許多國家的政府正在投資研究和開發活動，以調查戈謝病並開發新的治療方法。 還正在採取措施提供所有人都可以使用的優質醫療保健設施。 這與診斷技術的顯著改進相結合，為市場創造了光明的前景。 除此之外，人們越來越意識到 ERT 治療的替代品很容易獲得，例如有助於減少葡萄糖腦甘脂分解和積累的口服療法，這也促進了市場的增長。 一般來說，非處方藥 (OTC) 和仿製藥很容易通過處方獲得，以幫助緩解與戈謝病相關的疼痛。

主要市場細分

  • IMARC Group 分析了全球戈謝病市場每個細分市場的主要趨勢，並提供了 2023 年至 2028 年全球、區域和國家層面的預測。 該報告根據類型、診斷/治療方法和最終用戶對市場進行分類。

類型洞察

  • 1 型戈謝病
  • 戈謝病 2 型
  • 戈謝病 3 型
  • 其他
  • 本報告按類型對戈謝病市場進行了詳細的細分和分析。 這包括戈謝病 1 型、戈謝病 2 型、戈謝病 3 型等。 根據這份報告，戈謝病 1 型占最大部分。

診斷和治療見解

  • 診斷
  • 體檢
  • 驗血
  • 圖像檢查
  • 孕前檢查/產前檢查
  • 其他
  • 治療
  • 手術
  • 藥物治療
  • 其他
  • 該報告還提供了基於診斷和治療的戈謝病市場的詳細細分和分析。 這包括診斷（體檢、血液檢查、影像學檢查、孕前檢查、產前檢查等）和治療（手術、藥物治療等）。

最終用戶洞察

  • 醫院
  • 專科診所
  • 家庭護理
  • 其他
  • 該報告基於最終用戶對戈謝病市場進行了詳細的細分和分析。 這包括醫院、專科診所、家庭保健等。

地理洞察

  • 北美
  • 美國
  • 加拿大
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳大利亞
  • 印度尼西亞
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 意大利
  • 西班牙
  • 俄羅斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中東和非洲
  • 北美（美國、加拿大）、亞太地區（中國、日本、印度、韓國、澳大利亞、印度尼西亞等）、歐洲（德國、法國、英國、意大利、西班牙、俄羅斯等） 、拉丁美洲（巴西）、墨西哥等）以及中東和非洲進行了綜合分析。 除此之外，北美是戈謝病最大的市場。 推動北美戈謝病市場發展的因素包括遺傳異常的日益流行、成熟的醫療基礎設施的存在以及先進醫療技術的整合。

本報告中回答的關鍵問題

  • 戈謝病的全球市場迄今為止如何發展以及在未來幾年將如何發展？
  • 全球戈謝病市場的驅動因素、市場製約因素和機遇是什麼？
  • 主要區域市場在哪裡？
  • 哪些國家/地區是戈謝病最具吸引力的市場？
  • 按類型劃分的市場細分是什麼？
  • 診斷和治療的市場細分情況如何？
  • 最終用戶的市場細分情況如何？
  • 全球戈謝病市場的競爭結構如何？
  • 全球戈謝病市場的主要參與者/公司有哪些？

內容

第1章前言

第 2 章研究方法和範圍

  • 調查的目的
  • 利益相關者
  • 數據源
    • 主要信息
    • 次要信息
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章執行摘要

第4章介紹

  • 概覽
  • 主要行業趨勢

第 5 章全球戈謝病市場

  • 市場概覽
  • 市場結果
  • COVID-19 的影響
  • 市場預測

第 6 章按類型劃分的市場細分

  • 1 型戈謝病
    • 市場趨勢
    • 市場預測
  • 戈謝病 2 型
    • 市場趨勢
    • 市場展望
  • 戈謝病 3 型
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 7 章診斷和治療市場細分

  • 診斷名稱
    • 市場趨勢
    • 主要細分市場
      • 健康檢查
      • 驗血
      • 圖像檢查
      • 孕前檢查/產前檢查
      • 其他
    • 市場預測
  • 治療領域
    • 市場趨勢
    • 主要細分市場
      • 手術
      • 藥物治療
      • 其他
    • 市場預測

第 8 章最終用戶市場細分

  • 醫院
    • 市場趨勢
    • 市場預測
  • 專科診所
    • 市場趨勢
    • 市場預測
  • 家庭護理
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 9 章按區域劃分的市場細分

  • 北美
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場展望
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場展望
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場展望
    • 韓國市場
      • 市場趨勢
      • 市場展望
    • 澳大利亞
      • 市場趨勢
      • 市場展望
    • 印度尼西亞
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場展望
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 意大利
      • 市場趨勢
      • 市場展望
    • 西班牙
      • 市場趨勢
      • 市場展望
    • 俄羅斯
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場展望
    • 墨西哥
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家/地區劃分的市場細分
    • 市場預測

第 10 章：驅動因素、制約因素和機遇

  • 概覽
  • 司機
  • 抑製劑條件
  • 商機

第11章價值鏈分析

第 12 章：波特的五力分析

  • 概覽
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章競爭格局

  • 市場結構
  • 主要公司
  • 主要公司簡介
    • ISU Abxis Co. Ltd.
    • Johnson & Johnson
    • Pfizer Inc.
    • Protalix Biotherapeutics
    • Sanofi S.A
    • Takeda Pharmaceutical Company Limited
Product Code: SR1423A188_Report

Market Overview:

  • The global Gaucher disease market size reached US$ 1.55 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.35 Billion by 2028, exhibiting a growth rate (CAGR) of 7.07% during 2023-2028. Increasing number of patients suffering from Gaucher disease, extensive research and development (R&D) activities, and the easy availability of drugs represent some of the key factors driving the market.
  • Gaucher disease, also known as lysosomal storage disorder, is a rare genetic metabolic disorder that affects the ability of the body to break down and store fats. It is caused by glucocerebrosidase deficiency, which breaks down glucocerebroside fatty chemicals in the body. It is associated with an enlarged spleen and liver, anemia, easy bruising and bleeding, lung problems, fatigue, seizures, and bone abnormalities. It is diagnosed through various physical examinations, medical history, and laboratory tests, such as blood and imaging tests, and genetic testing to confirm the presence of a mutation in the gene. Gaucher disease can be treated using medications, injections, enzyme replacement therapy (ERT), bone marrow transplantation, and substrate reduction therapy (SRT), which aid in minimizing the pain associated with the symptoms and improve the quality of life.

Gaucher Disease Market Trends:

  • At present, the increasing prevalence of genetic abnormalities among individuals and the rising number of patients suffering from Gaucher disease represent one of the major factors bolstering the market growth around the world. Moreover, the growing aging population that is more prone to developing these medical disorders is resulting in an increasing demand for Gaucher disease treatment. In addition, there is a rise in the implementation of health insurance policies that provide financial assistance for Gaucher disease treatment and reduce medical expenses. Apart from this, the growing awareness about Gaucher disease, its symptoms, diagnosis, and the easy availability of the treatment options is influencing the market positively. Furthermore, governments of numerous countries are investing in research and development (R&D) activities to study Gaucher disease and develop new treatments. They are also undertaking measures to offer quality healthcare facilities that are accessible to all. This, coupled with significant improvements in the diagnostic technologies, is creating a positive outlook for the market. Besides this, the rising awareness about the easy availability of ERT treatment alternatives like oral therapies that help break down glucocerebroside and reduce the accumulation is contributing to the growth of the market. They generally involve generic drugs that are readily available over the counter (OTC) and by prescription for relieving pain associated with Gaucher disease.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each segment of the global Gaucher disease market, along with forecasts at the global, regional, and country level from 2023-2028. Our report has categorized the market based on type, diagnosis and treatment, and end user.

Type Insights:

  • Gaucher Disease Type 1
  • Gaucher Disease Type 2
  • Gaucher Disease Type 3
  • Others
  • The report has provided a detailed breakup and analysis of the Gaucher disease market based on the type. This includes Gaucher disease type 1, Gaucher disease type 2, Gaucher disease type 3, and others. According to the report, Gaucher disease type 1 represented the largest segment.

Diagnosis and Treatment Insights:

  • Diagnosis
  • Physical Exam
  • Blood Tests
  • Imaging Tests
  • Preconception Screening and Prenatal Testing
  • Others
  • Treatment
  • Surgery
  • Medication
  • Others
  • A detailed breakup and analysis of the Gaucher disease market based on the diagnosis and treatment has also been provided in the report. This includes diagnosis (physical exam, blood tests, imaging tests, preconception screening and prenatal testing, and others) and treatment (surgery, medication, and others).

End User Insights:

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others
  • The report has provided a detailed breakup and analysis of the Gaucher disease market based on the end user. This includes hospitals, specialty clinics, homecare, and others.

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for Gaucher disease. Some of the factors driving the North America Gaucher disease market included increasing prevalence of genetic abnormalities, the presence of a well-established healthcare infrastructure, the integration of advanced medical technologies, etc.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global Gaucher disease market. Detailed profiles of all major companies have also been provided. Some of the companies covered include ISU Abxis Co. Ltd., Johnson & Johnson, Pfizer Inc., Protalix Biotherapeutics, Sanofi S.A, Takeda Pharmaceutical Company Limited, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report

Key Questions Answered in This Report:

  • How has the global Gaucher disease market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global Gaucher disease market?
  • What are the key regional markets?
  • Which countries represent the most attractive Gaucher disease markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the diagnosis and treatment?
  • What is the breakup of the market based on the end user?
  • What is the competitive structure of the global Gaucher disease market?
  • Who are the key players/companies in the global Gaucher disease market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Gaucher Disease Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Gaucher Disease Type 1
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Gaucher Disease Type 2
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Gaucher Disease Type 3
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Diagnosis and Treatment

  • 7.1 Diagnosis
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Physical Exam
      • 7.1.2.2 Blood Tests
      • 7.1.2.3 Imaging Tests
      • 7.1.2.4 Preconception Screening and Prenatal Testing
      • 7.1.2.5 Others
    • 7.1.3 Market Forecast
  • 7.2 Treatment
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Surgery
      • 7.2.2.2 Medication
      • 7.2.2.3 Others
    • 7.2.3 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Specialty Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Homecare
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 ISU Abxis Co. Ltd.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Johnson & Johnson
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Pfizer Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Protalix Biotherapeutics
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Sanofi S.A
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Takeda Pharmaceutical Company Limited
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Gaucher Disease Market: Major Drivers and Challenges
  • Figure 2: Global: Gaucher Disease Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Gaucher Disease Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Gaucher Disease Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Gaucher Disease Market: Breakup by Diagnosis and Treatment (in %), 2022
  • Figure 6: Global: Gaucher Disease Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Gaucher Disease Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Gaucher Disease (Gaucher Disease Type 1) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Gaucher Disease (Gaucher Disease Type 1) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Gaucher Disease (Gaucher Disease Type 2) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Gaucher Disease (Gaucher Disease Type 2) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Gaucher Disease (Gaucher Disease Type 3) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Gaucher Disease (Gaucher Disease Type 3) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Gaucher Disease (Other Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Gaucher Disease (Other Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Gaucher Disease (Diagnosis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Gaucher Disease (Diagnosis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Gaucher Disease (Treatment) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Gaucher Disease (Treatment) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Gaucher Disease (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Gaucher Disease (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Gaucher Disease (Specialty Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Gaucher Disease (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Gaucher Disease (Homecare) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Gaucher Disease (Homecare) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Gaucher Disease (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Gaucher Disease (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: North America: Gaucher Disease Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: North America: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: United States: Gaucher Disease Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: United States: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Canada: Gaucher Disease Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Canada: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Asia-Pacific: Gaucher Disease Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Asia-Pacific: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: China: Gaucher Disease Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: China: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Japan: Gaucher Disease Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Japan: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: India: Gaucher Disease Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: India: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: South Korea: Gaucher Disease Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: South Korea: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Australia: Gaucher Disease Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Australia: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Indonesia: Gaucher Disease Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Indonesia: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Others: Gaucher Disease Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Others: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Europe: Gaucher Disease Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Europe: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Germany: Gaucher Disease Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Germany: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: France: Gaucher Disease Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: France: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: United Kingdom: Gaucher Disease Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: United Kingdom: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Italy: Gaucher Disease Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Italy: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Spain: Gaucher Disease Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Spain: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Russia: Gaucher Disease Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Russia: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Others: Gaucher Disease Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Others: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Latin America: Gaucher Disease Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Latin America: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Brazil: Gaucher Disease Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Brazil: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Mexico: Gaucher Disease Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Mexico: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Gaucher Disease Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Middle East and Africa: Gaucher Disease Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Middle East and Africa: Gaucher Disease Market: Breakup by Country (in %), 2022
  • Figure 76: Middle East and Africa: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Global: Gaucher Disease Industry: Drivers, Restraints, and Opportunities
  • Figure 78: Global: Gaucher Disease Industry: Value Chain Analysis
  • Figure 79: Global: Gaucher Disease Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Gaucher Disease Market: Key Industry Highlights, 2022 & 2028
  • Table 2: Global: Gaucher Disease Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Gaucher Disease Market Forecast: Breakup by Diagnosis and Treatment (in Million US$), 2023-2028
  • Table 4: Global: Gaucher Disease Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Gaucher Disease Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Gaucher Disease Market: Competitive Structure
  • Table 7: Global: Gaucher Disease Market: Key Players